OA
Schedule 13D filing
ORBIMED ADVISORS LLC disclosed a 11% stake in Electra Therapeutics, Inc. (ETRA)
ORBIMED ADVISORS LLC reported owning 11% of Electra Therapeutics, Inc. (ETRA) (6,885,170 shares) in a Schedule 13D filed Sep 25, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 25, 2026
- Source
- Schedule 13D
More ETRA insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.